DLL3-CAR-NK cells / Tianjin Medical University Cancer Institute and Hospital - LARVOL DELTA

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer (clinicaltrials.gov) - P2 | N=165 | Not yet recruiting | Sponsor: Tianjin Medical University Cancer Institute and Hospital

Biomarker • IO biomarker • New P2 trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer (clinicaltrials.gov) - P1 | N=18 | Recruiting | Sponsor: Tianjin Medical University Cancer Institute and Hospital

New P1 trial • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor